000			03436nam a22003735i 4500
001			280210
003			MX-SnUAN
005			20160429154014.0
007			cr nn 008mamaa
008			150903s2007 xxu| o |||| 0|eng d
020			_a9780387719962 _99780387719962
024	7		_a10.1007/9780387719962 _2doi
035			_avtls000332217
039		9	_a201509030757 _bVLOAD _c201404122053 _dVLOAD _c201404091823 _dVLOAD _y201402041023 _zstaff
040			_aMX-SnUAN _bspa _cMX-SnUAN _erda
050		4	_aRA1-1270
100	1		_aSchlander, Michael. _eautor _9304994
245	1	0	_aHealth Technology Assessments by the National Institute for Health and Clinical Excellence : _bA Qualitative Study / _cby Michael Schlander.
264		1	_aNew York, NY : _bSpringer New York, _c2007.
300			_brecurso en línea.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aInnovation and Valuation in Health Care
500			_aSpringer eBooks
505	0		_aA Note on Objectives and Methods -- NICE Appraisal Process -- NICE Appraisal of ADHD Treatments -- NICE Appraisal of ADHD Treatment Options: A Critique -- Discussion and Implications -- Which Way Forward?.
520			_aFirst in a new series on economic issues in the context of health care policy, Health Technology Assessments by the National Institute for Health and Clinical Excellence examines Britain’s highly acclaimed approach to cost-effectiveness analysis (CEA), and its international potential. The National Institute for Health and Clinical Excellence (NICE) has been regarded as a role model for the implementation of CEA, and is being closely watched by health care policy makers throughout Europe, and in the United States. This volume dissects the robustness of the agency’s technology appraisal processes as NICE evaluates innovative methods for diagnosis and intervention. Given the unique features of attention-deficit/hyperactivity disorder (ADHD)—starting with it being diagnosed mainly in children and adolescents, its high comorbidity with other psychiatric conditions, and its considerable economic impact—the disorder is a perfect focal point for discussion. Review of clinical issues in ADHD, including diagnostic criteria and the use of psychostimulants. Step-by-step explanation of the NICE appraisal process: valuation of treatment strategies for ADHD. Successes and limitations of NICE: an in-depth critique. Future directions and implications for health care prioritization in other countries. Balanced clinical and economic perspectives throughout the book. This is salient reading for public health professionals in health service administration, research, policy, and economics. Whether one’s interest is the robustness of the NICE method, or its application across clinical conditions or delivery systems, this book is a singular look into the real world of health care decision-making.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9780387719955
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-71996-2 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c280210 _d280210